Huijuan Dai
- Hepatology top 10%
-
- Cancer, Hypoxia, and Metabolism 3
- Transplantation top 10%
-
- Immune cells in cancer 3
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 2
-
- RNA modifications and cancer 5
-
- HER2/EGFR in Cancer Research 3
- Cancer Cells and Metastasis 2
-
- Chemotherapy-induced cardiotoxicity and mitigation 3
-
- Ferroptosis and cancer prognosis 2
In The Last Decade
Huijuan Dai
25 papers receiving 514 citations
Peers
Comparison fields: 5 of 74
- Hepatology 83
- Cancer Research 120
- Transplantation 21
- Nephrology 38
- Immunology 104
Countries citing papers authored by Huijuan Dai
This map shows the geographic impact of Huijuan Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huijuan Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huijuan Dai more than expected).
Fields of papers citing papers by Huijuan Dai
This network shows the impact of papers produced by Huijuan Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huijuan Dai. The network helps show where Huijuan Dai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huijuan Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 7 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 28 | |
| 5 | 2023 | 27 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 37 | |
| 9 | 2022 | 4 | |
| 10 | 2021 | 10 | |
| 11 | 2021 | 11 | |
| 12 | 2021 | 24 | |
| 13 | 2020 | 35 | |
| 14 | 2020 | 18 | |
| 15 | 2016 | 41 | |
| 16 | 2016 | 11 | |
| 17 | 2015 | 49 | |
| 18 | 2015 | 9 | |
| 19 | 2015 | 5 | |
| 20 | 2010 | 79 |
About Huijuan Dai
Huijuan Dai is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 518 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), HER2/EGFR in Cancer Research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Immune cells in cancer (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Ferroptosis and cancer prognosis (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Hepatology (83 citations), Cancer Research (120 citations) and Transplantation (21 citations). Huijuan Dai has collaborated with scholars based in China and Sweden. Frequent co-authors include Xiaonan Sheng, Qiang Xia, Yueyao Du, Qiang Xia, Shuyun Zhang, Jinsong Lu, En Wang, Suqin Zheng, Wenjin Yin and Jianjun Zhang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.